A Potential Target for Diabetic Vascular Damage: High Glucose-Induced Monocyte Extracellular Vesicles Impair Endothelial Cells by Delivering miR-142-5p

Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in bioengineering and biotechnology Vol. 10; p. 913791
Main Authors Zhang, Rui, Niu, Shuai, Rong, Zhihua, Li, Fengshi, Ni, Leng, Di, Xiao, Liu, Changwei
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 09.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells ( HG- THP-1 EVs and BG- THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT–qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG- THP-1 EVs, HG- THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG- THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT–qPCR results showed that HG- THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG- THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.
AbstractList Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (HG-THP-1 EVs and BG-THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT–qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG-THP-1 EVs, HG-THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG-THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT–qPCR results showed that HG-THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG-THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.
Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (HG-THP-1 EVs and BG-THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT-qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG-THP-1 EVs, HG-THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG-THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT-qPCR results showed that HG-THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG-THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (HG-THP-1 EVs and BG-THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT-qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG-THP-1 EVs, HG-THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG-THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT-qPCR results showed that HG-THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG-THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.
Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells ( HG- THP-1 EVs and BG- THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT–qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG- THP-1 EVs, HG- THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG- THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT–qPCR results showed that HG- THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG- THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.
Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells ( THP-1 EVs and THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT-qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to THP-1 EVs, THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT-qPCR results showed that THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.
Author Niu, Shuai
Rong, Zhihua
Li, Fengshi
Liu, Changwei
Ni, Leng
Di, Xiao
Zhang, Rui
AuthorAffiliation Department of Vascular Surgery , Peking Union Medical College Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China
AuthorAffiliation_xml – name: Department of Vascular Surgery , Peking Union Medical College Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China
Author_xml – sequence: 1
  givenname: Rui
  surname: Zhang
  fullname: Zhang, Rui
– sequence: 2
  givenname: Shuai
  surname: Niu
  fullname: Niu, Shuai
– sequence: 3
  givenname: Zhihua
  surname: Rong
  fullname: Rong, Zhihua
– sequence: 4
  givenname: Fengshi
  surname: Li
  fullname: Li, Fengshi
– sequence: 5
  givenname: Leng
  surname: Ni
  fullname: Ni, Leng
– sequence: 6
  givenname: Xiao
  surname: Di
  fullname: Di, Xiao
– sequence: 7
  givenname: Changwei
  surname: Liu
  fullname: Liu, Changwei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35615474$$D View this record in MEDLINE/PubMed
BookMark eNp1ksFu1DAQhiNUREvpA3BBPnLJYjtxHHNAqrZLu1IRCJVerYkzybpK4sV2KvZJeF2S3Ra1SJxsj__5fnn8v06OBjdgkrxldJFlpfrQVNbhglPOF4plUrEXyQnnqkhzVoqjJ_vj5CyEO0op40KKkr9KjjNRMJHL_CT5fU6-uYhDtNCRG_AtRtI4Ty4sVBitIbcQzNjBVIEeWvxIrmy7IZfdaFzAdD3Uo8GafHGDM7uIZPUrejDYdfueWwzWdBjIut-C9WQ11C5usJvNlpMokGpHLqbzPXo7tKS331OW81Rs3yQvG-gCnj2sp8mPz6ub5VV6_fVyvTy_Tk1eiJgyqJSouEBW01opXpgGGQPBm8aojFdQUw5McabqAoU0ikmGIIFlNTVllmenyfrArR3c6a23PfiddmD1vuB8q8HH-RF68hI0M1IWYHKJEqDgSBmVTV0qVqmJ9enA2o5Vj7WZpuqhewZ9fjPYjW7dvVaM52VZToD3DwDvfo4You5tmIcJA7oxaF5ISgtBmZik7556_TV5_NlJIA8C410IHhttbIRo3WxtO82onmOk9zHSc4z0IUZTJ_un8xH-_54_KhrNCA
CitedBy_id crossref_primary_10_3390_ijms26031008
crossref_primary_10_1186_s12933_023_01965_7
crossref_primary_10_1038_s42255_023_00971_z
crossref_primary_10_3390_ijms25020934
crossref_primary_10_53469_jcmp_2024_06_09__08
crossref_primary_10_1038_s41392_023_01333_7
crossref_primary_10_1007_s12026_024_09462_z
Cites_doi 10.1186/s12933-017-0513-y
10.3389/fimmu.2021.682948
10.1002/biof.1395
10.3390/antiox10081306
10.1155/2013/879516
10.1042/CS20180905
10.3390/antiox10091463
10.3892/ijmm.2021.5020
10.1016/j.phrs.2021.105868
10.3727/096504016X14719078133366
10.1177/2058738420909041
10.3389/fcell.2022.824165
10.1016/j.atherosclerosis.2010.01.035
10.3892/mmr.2015.3191
10.1007/s11010-017-3256-x
10.1186/1471-2105-15-293
10.1161/CIRCRESAHA.118.314601
10.1016/j.bbrc.2021.02.070
10.1016/s0092-8674(04)00045-5
10.1186/s12872-021-01893-y
10.1093/nar/gkx1141
10.14336/AD.2021.0708
10.1186/s13059-019-1629-z
10.3389/fcvm.2021.733985
10.1016/j.bbrc.2021.08.053
10.1016/j.imbio.2019.02.004
10.3390/cells10102663
10.3389/fphys.2018.01857
10.1093/eurheartj/ehx581
10.18632/aging.202829
10.1038/ng1536
10.1101/gr.082701.108
10.1007/s12011-021-02773-4
ContentType Journal Article
Copyright Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu.
Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu
Copyright_xml – notice: Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu.
– notice: Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fbioe.2022.913791
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

CrossRef
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
DocumentTitleAlternate Zhang et al
EISSN 2296-4185
ExternalDocumentID oai_doaj_org_article_1ab503c776ac47e7aa62e0107fd891b9
PMC9124888
35615474
10_3389_fbioe_2022_913791
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c465t-1ab95b25e1d0d9926cfe11a52ffc932bad02a19219d6e57c9171ea7a13d0c8343
IEDL.DBID M48
ISSN 2296-4185
IngestDate Wed Aug 27 01:17:43 EDT 2025
Thu Aug 21 18:19:16 EDT 2025
Fri Jul 11 16:28:01 EDT 2025
Thu Apr 03 06:56:30 EDT 2025
Thu Apr 24 23:06:46 EDT 2025
Tue Jul 01 02:45:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords miR-142-5p
monocytes
diabetes mellitus
extracellular vesicles
endothelial damage
Language English
License Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-1ab95b25e1d0d9926cfe11a52ffc932bad02a19219d6e57c9171ea7a13d0c8343
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology
Reviewed by: Shucong Li, Massachusetts Institute of Technology, United States
Huayi Wang, Chinese Institute for Brain Research, Beijing (CIBR), China
Edited by: Xiaoguang Wang, The Ohio State University, United States
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fbioe.2022.913791
PMID 35615474
PQID 2670065015
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_1ab503c776ac47e7aa62e0107fd891b9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9124888
proquest_miscellaneous_2670065015
pubmed_primary_35615474
crossref_citationtrail_10_3389_fbioe_2022_913791
crossref_primary_10_3389_fbioe_2022_913791
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-05-09
PublicationDateYYYYMMDD 2022-05-09
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-09
  day: 09
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in bioengineering and biotechnology
PublicationTitleAlternate Front Bioeng Biotechnol
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Liu (B15) 2018; 445
Krek (B14) 2005; 37
Lou (B18) 2017; 25
Miao (B20) 2013; 2013
Zhao (B32); 173
Karagkouni (B13) 2018; 46
Sáez (B23) 2019; 224
Liu (B17) 2020; 34
Hu (B9) 2018; 44
Maruhashi (B19) 2021; 10
Hoogeveen (B7) 2018; 39
Xu (B31) 2015; 11
Jin (B11) 2021; 48
Abd El-Khalik (B1) 2021; 200
Hur (B10) 2010; 211
Alonso-Piñeiro (B2) 2021; 10
Friedman (B5) 2009; 19
Bartel (B4) 2004; 116
Teodoro (B27) 2018; 9
Zhao (B33); 13
Bardou (B3) 2014; 15
Jurgielewicz (B12) 2021; 12
Sanwlani (B24) 2021; 10
Puhm (B22) 2019; 125
Thiem (B28) 2019; 133
Grieco (B6) 2021; 12
Liu (B16) 2019; 20
Wang (B29) 2021; 548
Xu (B30) 2021; 8
Pan (B21) 2021; 21
Sharma (B25) 2017; 16
Hu (B8) 2021; 575
Song (B26) 2022; 10
References_xml – volume: 16
  start-page: 33
  year: 2017
  ident: B25
  article-title: The Nuclear Factor (Erythroid-derived 2)-like 2 (Nrf2) Activator Dh404 Protects against Diabetes-Induced Endothelial Dysfunction
  publication-title: Cardiovasc Diabetol.
  doi: 10.1186/s12933-017-0513-y
– volume: 12
  start-page: 682948
  year: 2021
  ident: B6
  article-title: Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-To-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.682948
– volume: 44
  start-page: 123
  year: 2018
  ident: B9
  article-title: Dihydromyricetin Inhibits NLRP3 Inflammasome-dependent Pyroptosis by Activating the Nrf2 Signaling Pathway in Vascular Endothelial Cells
  publication-title: Biofactors
  doi: 10.1002/biof.1395
– volume: 10
  start-page: 1306
  year: 2021
  ident: B19
  article-title: Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction
  publication-title: Antioxidants
  doi: 10.3390/antiox10081306
– volume: 2013
  start-page: 1
  year: 2013
  ident: B20
  article-title: Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice
  publication-title: Oxidative Med. Cell. Longev.
  doi: 10.1155/2013/879516
– volume: 133
  start-page: 195
  year: 2019
  ident: B28
  article-title: Trained Immunity and Diabetic Vascular Disease
  publication-title: Clin. Sci. (Lond)
  doi: 10.1042/CS20180905
– volume: 10
  start-page: 1463
  year: 2021
  ident: B2
  article-title: Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress
  publication-title: Antioxidants
  doi: 10.3390/antiox10091463
– volume: 48
  start-page: 187
  year: 2021
  ident: B11
  article-title: Oxymatrine Attenuates Oxidized Low-density L-ipoprotein-induced HUVEC I-njury by I-nhibiting NLRP3 I-nflammasome-mediated P-yroptosis via the A-ctivation of the SIRT1/Nrf2 S-ignaling P-athway
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2021.5020
– volume: 173
  start-page: 105868
  ident: B32
  article-title: Targeting the microRNAs in Exosome: A Potential Therapeutic Strategy for Alleviation of Diabetes-Related Cardiovascular Complication
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2021.105868
– volume: 25
  start-page: 65
  year: 2017
  ident: B18
  article-title: MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells
  publication-title: Oncol. Res.
  doi: 10.3727/096504016X14719078133366
– volume: 34
  start-page: 205873842090904
  year: 2020
  ident: B17
  article-title: miR-142-5p Regulates the Progression of Diabetic Retinopathy by Targeting IGF1
  publication-title: Int. J. Immunopathol. Pharmacol.
  doi: 10.1177/2058738420909041
– volume: 10
  start-page: 824165
  year: 2022
  ident: B26
  article-title: The Molecular Pathways of Pyroptosis in Atherosclerosis
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2022.824165
– volume: 211
  start-page: 69
  year: 2010
  ident: B10
  article-title: Protective Effects of Magnesium Lithospermate B against Diabetic Atherosclerosis via Nrf2-ARE-NQO1 Transcriptional Pathway
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2010.01.035
– volume: 11
  start-page: 3229
  year: 2015
  ident: B31
  article-title: Upregulation of miR-142-5p in Atherosclerotic Plaques and Regulation of Oxidized Low-Density Lipoprotein-Induced Apoptosis in Macrophages
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2015.3191
– volume: 445
  start-page: 105
  year: 2018
  ident: B15
  article-title: Fenofibrate Ameliorates Diabetic Retinopathy by Modulating Nrf2 Signaling and NLRP3 Inflammasome Activation
  publication-title: Mol. Cell Biochem.
  doi: 10.1007/s11010-017-3256-x
– volume: 15
  start-page: 293
  year: 2014
  ident: B3
  article-title: Jvenn: an Interactive Venn Diagram Viewer
  publication-title: BMC Bioinforma.
  doi: 10.1186/1471-2105-15-293
– volume: 125
  start-page: 43
  year: 2019
  ident: B22
  article-title: Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.118.314601
– volume: 548
  start-page: 127
  year: 2021
  ident: B29
  article-title: Melatonin Attenuates Restenosis after Vascular Injury in Diabetic Rats through Activation of the Nrf2 Signaling Pathway
  publication-title: Biochem. Biophysical Res. Commun.
  doi: 10.1016/j.bbrc.2021.02.070
– volume: 116
  start-page: 281
  year: 2004
  ident: B4
  article-title: MicroRNAs
  publication-title: Cell
  doi: 10.1016/s0092-8674(04)00045-5
– volume: 21
  start-page: 77
  year: 2021
  ident: B21
  article-title: Circulating Level of microRNA-142-5p Is a Potential Biomarker for Predicting In-Stent Restenosis: a Case-Control Study
  publication-title: BMC Cardiovasc Disord.
  doi: 10.1186/s12872-021-01893-y
– volume: 46
  start-page: D239
  year: 2018
  ident: B13
  article-title: DIANA-TarBase V8: a Decade-Long Collection of Experimentally Supported miRNA-Gene Interactions
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkx1141
– volume: 12
  start-page: 1476
  year: 2021
  ident: B12
  article-title: Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles
  publication-title: Aging Dis.
  doi: 10.14336/AD.2021.0708
– volume: 20
  start-page: 18
  year: 2019
  ident: B16
  article-title: Prediction of Functional microRNA Targets by Integrative Modeling of microRNA Binding and Target Expression Data
  publication-title: Genome Biol.
  doi: 10.1186/s13059-019-1629-z
– volume: 8
  start-page: 733985
  year: 2021
  ident: B30
  article-title: Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis
  publication-title: Front. Cardiovasc. Med.
  doi: 10.3389/fcvm.2021.733985
– volume: 575
  start-page: 65
  year: 2021
  ident: B8
  article-title: Exosomal Long Non-coding RNA LIPCAR Derived from oxLDL-Treated THP-1 Cells Regulates the Proliferation of Human Umbilical Vein Endothelial Cells and Human Vascular Smooth Muscle Cells
  publication-title: Biochem. Biophysical Res. Commun.
  doi: 10.1016/j.bbrc.2021.08.053
– volume: 224
  start-page: 325
  year: 2019
  ident: B23
  article-title: Exosomes Derived from Monocytes and from Endothelial Cells Mediate Monocyte and Endothelial Cell Activation under High D-Glucose Conditions
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2019.02.004
– volume: 10
  start-page: 2663
  year: 2021
  ident: B24
  article-title: Role of Extracellular Vesicles in Cell Death and Inflammation
  publication-title: Cells
  doi: 10.3390/cells10102663
– volume: 9
  start-page: 1857
  year: 2018
  ident: B27
  article-title: Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2018.01857
– volume: 39
  start-page: 3521
  year: 2018
  ident: B7
  article-title: Monocyte and Haematopoietic Progenitor Reprogramming as Common Mechanism Underlying Chronic Inflammatory and Cardiovascular Diseases
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehx581
– volume: 13
  start-page: 11363
  ident: B33
  article-title: Melatonin Attenuates Smoking-Induced Atherosclerosis by Activating the Nrf2 Pathway via NLRP3 Inflammasomes in Endothelial Cells
  publication-title: Aging
  doi: 10.18632/aging.202829
– volume: 37
  start-page: 495
  year: 2005
  ident: B14
  article-title: Combinatorial microRNA Target Predictions
  publication-title: Nat. Genet.
  doi: 10.1038/ng1536
– volume: 19
  start-page: 92
  year: 2009
  ident: B5
  article-title: Most Mammalian mRNAs Are Conserved Targets of microRNAs
  publication-title: Genome Res.
  doi: 10.1101/gr.082701.108
– volume: 200
  start-page: 1677
  year: 2021
  ident: B1
  article-title: The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling
  publication-title: Biol. Trace Elem. Res.
  doi: 10.1007/s12011-021-02773-4
SSID ssj0001257582
Score 2.2414052
Snippet Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 913791
SubjectTerms Bioengineering and Biotechnology
diabetes mellitus
endothelial damage
extracellular vesicles
miR-142-5p
monocytes
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1da9YwFA6yK70QN7_qnETwSqhr0nw03s3tnVNQRLaxu5JPLGzt2NuJ-yX-XU-S7qWviN542TYhh5yT5DnpkycIvaosY1RqW_IQj-TAolNqL-rSac2Nss5pE_c7Pn0WRyfs4xk_m131FTlhWR44d9wu0YZXtZVSaMukl1oL6iGJkME1iph0dA_WvFkylXdXAIY0NP_GhCxM7QbTDVEWk9I3itRJk3O2ECW9_j-BzN-5krPF5_ABuj-hRryXrd1Ed3y_he7NtAQfop97-MswRu4PFDxO_G4MgBRnyktn8enEOcUH-gImkbc4Ujzw-0xZL-MVHtY7DGN8sDejx4sfYEjc1k91Tv0y8efwB5g-uiu86F08unUeG9uHQktsbvABPH9P5uCL7mtJGCSgl4_QyeHieP-onG5dKC0TfCyhwxU3lHviKqcUFTZ4QjSnIVgAe0a7iuqooqac8FxayPeI11KT2lW2qVn9GG30Q--fIhyM8kzVPNRCM9I4JYJtAlPCVR7yGlmg6tYFrZ0kyePNGOctpCbRa23yWhu91mavFej1qspl1uP4W-F30a-rglFKO72AAGunAGv_FWAFenkbFS0MvdjxuvfD9bKl8YgTIFzCC_QkR8mqqRpwKWeSFUiuxc-aLetf-u5bkvdWALmapnn2P4zfRndjfySGpnqONsara78DKGo0L9KA-QXU7hzd
  priority: 102
  providerName: Directory of Open Access Journals
Title A Potential Target for Diabetic Vascular Damage: High Glucose-Induced Monocyte Extracellular Vesicles Impair Endothelial Cells by Delivering miR-142-5p
URI https://www.ncbi.nlm.nih.gov/pubmed/35615474
https://www.proquest.com/docview/2670065015
https://pubmed.ncbi.nlm.nih.gov/PMC9124888
https://doaj.org/article/1ab503c776ac47e7aa62e0107fd891b9
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqIqFyQHw3QCsjcUJKiR07jpFQVdotBakIoW7VW-TYDkTaJmU3Rd1fwt9lxsmuumjFgWMSW3E8Y8-byfMMIa8TKwRXxsaywiM5YHRi47M0dsbIUlvnTInxjtMv2clYfL6QFxtkUd5qmMDZWtcO60mNp5O9m5_zfVjw79HjBHv7tirrFjNecr6nWarwLPsdMEwKCxqcDmi_D7kANsl5_29zfc8tcjcFRCGFEiuGKuTzXwdC_-ZS3jJOxw_I_QFV0oNeDR6SDd88Ivdu5Rp8TH4f0K9th9wgaHgW-N8UACvtKTG1pecDJ5UemUvYZN5RpIDQjz2lPcYSH9Y7CntAa-edp6MbGAiG_UOfcz8L_Dr6CbaXekpHjcOjXRN82SE0mtFyTo_g-lcYDr2sv8VMgIN69YSMj0dnhyfxUJUhtiKTXcxMqWXJpWcucVrzzFaeMSN5VVkAg6VxCTeYZU27zEtlwR9k3ijDUpfYPBXpU7LZtI3fJrQqtRc6lVWaGcFyp7PK5pXQmUs8-D0qIslCBIUdUpZj5YxJAa4LCrAIAixQgEUvwIi8WXa56vN1_KvxB5TrsiGm2g432un3Yli5BXyvTFKrVGasUF4Zk3EPXqyqXK5ZqSPyaqEVBSxNnHjT-PZ6VnA8AgUImMmIPOu1ZPmqhZZFRK3oz8pYVp809Y-Q_lsDJMvz_Pl_93xBtnASAm1TvySb3fTa7wC06srdEJLYDcvmD1IMJnI
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Potential+Target+for+Diabetic+Vascular+Damage%3A+High+Glucose-Induced+Monocyte+Extracellular+Vesicles+Impair+Endothelial+Cells+by+Delivering+miR-142-5p&rft.jtitle=Frontiers+in+bioengineering+and+biotechnology&rft.au=Zhang%2C+Rui&rft.au=Niu%2C+Shuai&rft.au=Rong%2C+Zhihua&rft.au=Li%2C+Fengshi&rft.date=2022-05-09&rft.pub=Frontiers+Media+S.A&rft.eissn=2296-4185&rft.volume=10&rft_id=info:doi/10.3389%2Ffbioe.2022.913791&rft_id=info%3Apmid%2F35615474&rft.externalDocID=PMC9124888
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-4185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-4185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-4185&client=summon